1. Liang, Junjie, Yao, Nan, Deng, Bo, Cao, Mingrong, Hong, Jian. 2024. GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma. In Journal of cellular physiology, 239, e31237. doi:10.1002/jcp.31237. https://pubmed.ncbi.nlm.nih.gov/38468464/
2. Bu, Fanqin, Zhu, Xiaojian, Zhu, Jinfeng, Lin, Kang, Huang, Jun. 2020. Bioinformatics Analysis Identifies a Novel Role of GINS1 Gene in Colorectal Cancer. In Cancer management and research, 12, 11677-11687. doi:10.2147/CMAR.S279165. https://pubmed.ncbi.nlm.nih.gov/33235499/
3. Chen, Zhenfa, Wang, Ting, Li, Cui, Wang, Jundong, Li, Shufeng. 2023. FOXP1-GINS1 axis promotes DLBCL proliferation and directs doxorubicin resistance. In Journal of Cancer, 14, 2289-2300. doi:10.7150/jca.85906. https://pubmed.ncbi.nlm.nih.gov/37576391/
4. Li, Sheng, Wu, Lina, Zhang, Hong, Dong, Bin, Cao, Guang. 2021. GINS1 Induced Sorafenib Resistance by Promoting Cancer Stem Properties in Human Hepatocellular Cancer Cells. In Frontiers in cell and developmental biology, 9, 711894. doi:10.3389/fcell.2021.711894. https://pubmed.ncbi.nlm.nih.gov/34414190/
5. Zhao, Huanhuan, He, Xiaoxia, Ma, Zhanbei. . Identification of GINS1 as a potential prognostic biomarker for sarcoma using bioinformatic analysis. In Translational cancer research, 12, 1021-1032. doi:10.21037/tcr-23-524. https://pubmed.ncbi.nlm.nih.gov/37180662/
6. Hou, Shiyang, Zhang, Jie, Chi, Xiaoqian, Kang, Chunbo, Shan, Haifeng. . Roles of DSCC1 and GINS1 in gastric cancer. In Medicine, 102, e35681. doi:10.1097/MD.0000000000035681. https://pubmed.ncbi.nlm.nih.gov/37904396/
7. Ge, Ruixiang, Wang, Chenci, Liu, Jiangang, Jiang, Xiaochun, Liu, Zhuohao. . A Novel Tumor-Promoting Role for Nuclear Factor IX in Glioblastoma Is Mediated through Transcriptional Activation of GINS1. In Molecular cancer research : MCR, 21, 189-198. doi:10.1158/1541-7786.MCR-22-0504. https://pubmed.ncbi.nlm.nih.gov/36469009/
8. Fu, Qiqi, Zheng, Hang, Wang, Xia, Liu, Tao, Peng, Jianping. 2024. GINS1 promotes the initiation and progression of bladder cancer by activating the AKT/mTOR/c-Myc signaling pathway. In Experimental cell research, 440, 114125. doi:10.1016/j.yexcr.2024.114125. https://pubmed.ncbi.nlm.nih.gov/38880324/